Pathological analysis revealed that four out of the five Rb+/−7−/− tumor lesions were medullary thyroid carcinomas, suggesting that loss of E2F7 aggravates the malignant progression of Rb-deficient thyroid tumors (Figure 3E,F). Here, E2F7 is linked to neoplasm.